Page last updated: 2024-09-03

imatinib mesylate and Delayed Hypersensitivity

imatinib mesylate has been researched along with Delayed Hypersensitivity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bulur, PA; Dietz, AB; Knutson, GJ; Litzow, MR; Souan, L; Vuk-Pavlovic, S	1

Other Studies

1 other study(ies) available for imatinib mesylate and Delayed Hypersensitivity

Article	Year
Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. Blood, 2004, Aug-15, Volume: 104, Issue:4 Topics: Animals; Apoptosis; Benzamides; Cell Proliferation; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Humans; Hypersensitivity, Delayed; Imatinib Mesylate; Inhibitory Concentration 50; Lymphocyte Activation; Mice; Phytohemagglutinins; Piperazines; Pyrimidines; Resting Phase, Cell Cycle; Spleen; T-Lymphocytes	2004

Article

Year

Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo.

Blood, 2004, Aug-15, Volume: 104, Issue:4

Topics: Animals; Apoptosis; Benzamides; Cell Proliferation; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Humans; Hypersensitivity, Delayed; Imatinib Mesylate; Inhibitory Concentration 50; Lymphocyte Activation; Mice; Phytohemagglutinins; Piperazines; Pyrimidines; Resting Phase, Cell Cycle; Spleen; T-Lymphocytes

2004